PrEPVacc
PrEP Vacc Registration Cohort Get Involved Contact Member's Area
Latest News News by partner In the Media Journal Publications List Research Dissemination News Archive
Partners Organisation and Governance Our Funders FAQs
PrEPVaccRegistration CohortGet Involved News Latest News News by partner In the Media Journal Publications List Research Dissemination News Archive About Partners Organisation and Governance Our Funders FAQs ContactMember's Area
PrEPVacc
An African-led, European-supported HIV prevention project running in four countries in East and Southern Africa from 2018 to 2024

PrEPVacc News

PrEPVacc features in BBC’s 'Focus on Africa'
PrEPVacc features in BBC’s 'Focus on Africa'
MRC/UVRI and LSHTM UgandaPrEP Vacc17 December 2020Media
NTV reports on PrEPVacc's first enrolments
NTV reports on PrEPVacc's first enrolments
MRC/UVRI and LSHTM UgandaPrEP Vacc16 December 2020Media
First enrolments to PrEPVacc clinical trial at Masaka
First enrolments to PrEPVacc clinical trial at Masaka
MRC/UVRI and LSHTM UgandaPrEP Vacc16 December 2020
PrEPVacc COVID-19 Update III – November 2020
PrEPVacc COVID-19 Update III – November 2020
PrEP Vacc13 November 2020
PrEPVacc welcomes results of HPTN 084 injectable PrEP study
PrEPVacc welcomes results of HPTN 084 injectable PrEP study
MRC CTU at UCL, SAMRCPrEP Vacc11 November 2020
PrEPVacc leaders contribute to future design of HIV prevention trials
PrEPVacc leaders contribute to future design of HIV prevention trials
MRC/UVRI and LSHTM Uganda, MRC CTU at UCLPrEP Vacc6 November 2020
First PrEPVacc SIV held at Masaka site
First PrEPVacc SIV held at Masaka site
MRC/UVRI and LSHTM UgandaPrEP Vacc23 October 2020
Leaflet for PrEPVacc participants published
Leaflet for PrEPVacc participants published
INS, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc20 September 2020
GPP training for PrEPVacc partners: our experience and lessons
GPP training for PrEPVacc partners: our experience and lessons
SAMRCPrEP Vacc18 August 2020
MUHAS site improves retention through active tracking and participants’ engagement meetings
MUHAS site improves retention through active tracking and participants’ engagement meetings
MUHASPrEP Vacc9 July 2020
PrEPVacc COVID-19 Update II – July 2020
PrEPVacc COVID-19 Update II – July 2020
PrEP Vacc8 July 2020
The search for an HIV vaccine: Professor Jonathan Weber reflects on his career
The search for an HIV vaccine: Professor Jonathan Weber reflects on his career
IMPERIALPrEP Vacc22 May 2020
Pontiano Kaleebu elected Fellow of the Academy of Medical Sciences
Pontiano Kaleebu elected Fellow of the Academy of Medical Sciences
MRC/UVRI and LSHTM UgandaPrEP Vacc15 May 2020
PrEPVacc COVID-19 Update - April 2020
PrEPVacc COVID-19 Update - April 2020
PrEP Vacc15 April 2020
Tribute to Gita Ramjee
Tribute to Gita Ramjee
SAMRCPrEP Vacc13 April 2020 Comment
Halted HIV vaccine trials were not a waste of time - UVRI
Halted HIV vaccine trials were not a waste of time - UVRI
MRC/UVRI and LSHTM UgandaPrEP Vacc6 February 2020Media
'Prof Kaleebu won’t tire until Aids cure is found' - The Observer
'Prof Kaleebu won’t tire until Aids cure is found' - The Observer
MRC/UVRI and LSHTM UgandaPrEP Vacc27 January 2020Media
Tanzania PrEPVacc site assessment visits completed
Tanzania PrEPVacc site assessment visits completed
NIMR-MMRC, MUHASPrEP Vacc24 January 2020
Cape Argus reports on PrEPVacc study application
Cape Argus reports on PrEPVacc study application
SAMRCPrEP Vacc24 January 2020Media
SAMRC Durban research team members participate in a Gender Based Violence Workshop
SAMRC Durban research team members participate in a Gender Based Violence Workshop
SAMRCPrEP Vacc10 December 2019
Newer Older
03-Yellow_EDCTP.png
flag_yellow_low.jpg
 

This project is part of the EDCTP2 Programme supported by the European Union

 
prepvacc@gmail.com
Hours
Featured
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
PrEPVacc Vaccine Trial Results Dissemination to participants in Masaka, Uganda
PrEPVacc Vaccine Trial Results Dissemination to participants in Masaka, Uganda
PrEPVacc meets the media in Masaka
PrEPVacc meets the media in Masaka
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
Joining the studyFAQs Partners of PrEPVacc
PrEPVacc-logo-reverse-rgb.png
 

Contact: prepvacc@gmail.com | Accessibility

© PrEPVacc Investigators 2023 | All rights reserved